Valuation (53%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -29.13 | 28.89 |
PEG Ratio (TTM) | -17.19 | 3.65 |
P/S Ratio (TTM) | 0.61 | 5.93 |
P/B Ratio (TTM) | 1.39 | 19.26 |
P/FCF Ratio (TTM) | 69.18 | 25.60 |
Price to 5YR AVG Earnings Ratio | 16.17 | 36.96 |
Price to 5YR AVG FCF Ratio | 8.75 | 32.80 |
Profitability (5%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.72% | 8.99% |
ROE (TTM) | -4.79% | 75.35% |
Net Profit Margin (TTM) | -2.10% | 20.09% |
ROIC 5YR AVG | 9.95% | 58.10% |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -798.32% | 24.90% | -27.31% |
Revenue | -1.16% | 7.97% | 3.21% |
Net Income | -803.52% | 26.33% | -26.33% |
Cash Flow | 62.06% | 1,157.14% | 727.89% |
Health (77%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.99 | 1.35 |
Quick Ratio (TTM) | 2.99 | 1.36 |
D/E Ratio (TTM) | 0.05 | 0.94 |
Interest Coverage (TTM) | -0.83 | 24.59 |
Piotroski F-Score | 3 | 8 |
Altman Z-Score | 5.76 | 3.68 |
LTL to 5YR AVG FCF | 0.29 | 3.10 |
Shares Outstanding Growth 5YR AVG | 1.19% | -0.48% |